Karuna Therapeutics Inc. (KRTX) PT Raised to $332 at Goldman Sachs

August 12, 2022 3:13 AM EDT
Get Alerts KRTX Hot Sheet
Price: $224.93 +0.19%

Rating Summary:
    16 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 4 | New: 31
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Karuna Therapeutics Inc. (NASDAQ: KRTX) to $332.00 (from $278.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change